What is the recommended tapering schedule for prednisone?

Prednisone Taper Recommendations

Taper prednisone gradually rather than abruptly, with the specific schedule depending on dose, duration of therapy, and underlying condition—but for short-term therapy (<3-4 weeks), you can stop without tapering regardless of dose. 1

Duration-Based Approach

Short-Term Therapy (<3-4 weeks)

• No taper required: Stop abruptly regardless of dose 1
• Low risk of HPA axis suppression
• Exception: Consider patient-specific factors like concurrent conditions requiring stress dosing

Long-Term Therapy (≥3-4 weeks)

The taper strategy depends on your current dose:

High-Dose Range (>30 mg/day prednisone equivalent)

• Taper faster with larger decrements
• Reduce to 10 mg/day within 4-8 weeks 2
• Example: Decrease by 5-10 mg every 1-2 weeks

Medium-Dose Range (10-30 mg/day)

• Moderate taper speed
• Reduce by 2.5-5 mg every 1-2 weeks until reaching 10 mg/day 3

Low-Dose Range (approaching physiologic dose of 5-7.5 mg/day)

• Slow taper is critical: Reduce by 1 mg every 4 weeks 2
• Alternative: Use alternate-day dosing (e.g., 10/7.5 mg alternating days) 2
• Continue until complete discontinuation if disease permits

Physiologic Dose Range (≤5 mg/day)

• Consider testing morning cortisol before further taper 1
• If cortisol >300 nmol/L (10 μg/dL): Safe to stop 1
• If cortisol 150-300 nmol/L (5-10 μg/dL): Continue physiologic dose, retest in weeks to months 1
• If cortisol <150 nmol/L (5 μg/dL): Continue physiologic dose, retest in several months 1

Disease-Specific Considerations

Autoimmune Hepatitis

• Initial: 60 mg daily (monotherapy) or 30 mg daily (with azathioprine) 3
• Week 1-4: Taper as outlined (60→40→30→30 or 30→20→15→15)
• Maintenance: Reduce by 5 mg/week until 10 mg/day, then by 2.5 mg/week to as low as 5 mg/day 3
• Some patients respond to minuscule doses (0.05 mg/kg/day)

Polymyalgia Rheumatica

• Initial taper: Reach 10 mg/day within 4-8 weeks 2
• Maintenance taper: 1 mg every 4 weeks once remission achieved 2
• Total duration typically 12-24 months

Atopic Dermatitis

• Avoid chronic use: Use only as short-term bridge therapy 4
• Taper required to prevent adrenal suppression
• Expect rebound flare upon discontinuation 4

Critical Safety Points

Adrenal Insufficiency Prevention

• Never stop abruptly after ≥3-4 weeks of therapy 1, 5
• Educate patients on stress dosing for illness, surgery, or trauma 1, 6
• Consider medical alert identification for patients on chronic therapy 6
• HPA axis suppression may persist up to 12 months after stopping 5

Monitoring During Taper

• Assess for signs/symptoms of adrenal insufficiency: fatigue, weakness, nausea, hypotension 1
• Distinguish from glucocorticoid withdrawal syndrome (myalgia, arthralgia, malaise without true insufficiency) 1
• If withdrawal syndrome is severe, temporarily increase to last tolerated dose and slow taper 1

When to Hold or Reverse Taper

• Active underlying disease requiring continued treatment 1
• Stress situations (infection, surgery, trauma): Increase to stress dosing 6, 5
• Disease relapse: Return to pre-relapse dose 2

Practical Administration

• Timing: Give morning dose before 9 AM to minimize HPA suppression 5
• Single daily dose preferred over divided dosing (except for specific situations like night pain at low doses) 2
• Take with food to reduce gastric irritation 5
• Switch from long-acting glucocorticoids (dexamethasone) to short-acting (prednisone, hydrocortisone) before tapering 1

Common Pitfalls

1. Tapering too quickly at low doses: The final taper from 10 mg to 0 mg requires the most caution—use 1 mg decrements every 4 weeks 2
2. Not educating patients about stress dosing: This can lead to adrenal crisis during intercurrent illness 1, 6
3. Testing cortisol while on supraphysiologic doses: Wait until near-physiologic dosing before assessing HPA recovery 1
4. Confusing withdrawal syndrome with true adrenal insufficiency: Withdrawal symptoms don't require full-dose resumption, just slower taper 1